Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study.
Saved in:
| Title: | Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study. |
|---|---|
| Authors: | Yeh YT; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Lo SC; Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung, Taiwan., Huang CN; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Yang YS; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung, Taiwan., Liao PL; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan., Kornelius E; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung, Taiwan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Jul 28; Vol. 16, pp. 1617534. Date of Electronic Publication: 2025 Jul 28 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
